HealCo

HealCo is a healthcare governance infrastructure company that helps self-funded employers control specialty care costs by governing where care enters the system. Rather than replacing health plans or TPAs, HealCo sits as an operating layer between payment and care delivery, routing members to cost-effective first-touch providers and logging every decision as auditable governance data. The company's three-layer stack includes Maestro (a routing rail that triages member symptoms via text to governed providers), Decision Desk (a governance subscription software that records and attributes care pathway decisions), and HealCoHP (a reference health plan that serves as a validation environment). This architecture targets the $1T employer-sponsored health market, beginning with self-funded employers who carry full financial risk and have legal authority to govern their plans.

Employer healthcare costs have risen over 70% in the past decade while wages grew only ~30%, with family coverage now exceeding $24,000/year. The root cause is not pricing but governance: care enters a fragmented system where provider prices vary 2–4x within the same market, site-of-service drives large cost differences, and employers have no visibility or control over where care begins. Risk is visible in aggregate but not governed at entry.

HealCo governs where care begins through its Maestro routing rail (member texts a symptom, Maestro triages to a governed first-touch provider — DPC, imaging, specialist, pharmacy, or bundle) and Decision Desk (real-time plan-level governance visibility, structured decision sessions, and exportable governance records). The governed pathway for an MSK episode costs ~$13,100 vs. ~$47,000 via the traditional pathway. No TPA replacement is required; HealCo integrates as an audit and routing layer over existing claims rails.

HealCo has generated $286K in total revenue ($161K governance ARR), is cash-flow positive, and has 300+ covered lives on its reference plan (HealCoHP). The reference environment demonstrates 30% lower total cost versus PPO baseline, and the company has an active employer pipeline across multiple markets with 3–4 self-funded employer deployments underway.